Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Enterprise Value (2022 - 2026)

Cannabis Bioscience International Holdings' Enterprise Value history spans 5 years, with the latest figure at -$90.0 for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 83.58% to -$90.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$90.0, a 83.58% increase, with the full-year FY2025 number at -$12952.0, down 1615.5% from a year prior.
  • Enterprise Value hit -$90.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from -$132.0 in the prior quarter.
  • Over the last five years, Enterprise Value for CBIH hit a ceiling of -$90.0 in Q1 2026 and a floor of -$25655.0 in Q1 2023.
  • Historically, Enterprise Value has averaged -$5800.4 across 5 years, with a median of -$881.5 in 2024.
  • Biggest five-year swings in Enterprise Value: skyrocketed 98.6% in 2023 and later tumbled 1615.5% in 2025.
  • Tracing CBIH's Enterprise Value over 5 years: stood at -$24089.0 in 2022, then skyrocketed by 98.6% to -$337.0 in 2023, then tumbled by 197.33% to -$1002.0 in 2024, then soared by 86.83% to -$132.0 in 2025, then surged by 31.82% to -$90.0 in 2026.
  • Business Quant data shows Enterprise Value for CBIH at -$90.0 in Q1 2026, -$132.0 in Q4 2025, and -$223.0 in Q3 2025.